This drugmaker is taking an unprecedented approach to getting its cancer treatment approved (LOXO)

Cancer chemotherapeutic strategy shift… to the molecular target.


The ‘Research Panel’ during Oct. 24th visit of Senator Manchin to WVU to discuss the opioid addiction crisis


From left to right: Dr. Erin Winstanley (WVU Schools of Medicine and Pharmacy), Dr. David Siderovski (WVU School of Medicine), Dr. Judith Feinberg (WVU School of Medicine), and Dr. Rob Bossarte (Director, WVU Injury Control Research Center).